...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New presentations

Anyone know when we might get another update?Funds are due before A hug 31st.


Aug 17, 2020 02:02PM
Share
New Message
Please login to post a reply